According to a post on the FDA’s website, Harmony Biosciences’ treatment of Prader-Willi syndrome received orphan designation.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HRMY:
